Dr. David A. Bennett is the director of the Rush Alzheimer’s Disease Center at Rush University Medical Center, Chicago. David serves on numerous national and international advisory and editorial boards, and is currently a member of the National Advisory Council on Aging for the National Institutes of Health. He has more than 800 peer-reviewed manuscript publications, with more than 107,000 citations and an h index of 156. He was the recipient of the 2018 Potamkin Prize for Research on Pick’s and Alzheimer’s and related dementia.
David presents two community-based clinical-pathologic cohort studies of aging dementia, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP). Together, the "ROSMAP" cohorts provide up to 25 annual waves of clinical data on nearly 3,700 persons and more than 1600 autopsies leveraged for deep, multilevel -omic data generation. These data feed the AMP-AD drug discovery pipeline to identify novel therapeutic targets for AD and cognitive decline.
This is part of the AMP-AD Knowledge Portal webinar series, an opportunity to discuss data, analysis, and tools for the study of Alzheimer’s disease generated through the National Institute on Aging’s Translational Research Program. It features speakers from the AMP-AD Target Discovery Program and associated consortia.